NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program
Amount Raised
$196 Million
Round Type
Series A
NetherlandsBiotechnologyHealth CareTherapeuticsDescription
NewAmsterdam Pharma (NAP), a clinical stage company focused on the research and development of transformative therapies for cardio-metabolic diseases, today announced completion of a $196M (€160M) Series A funding round.
Quick answer
NewAmsterdam Pharma raised $196 Million in a Series A round, dated January 14, 2021. NewAmsterdam Pharma is based in Netherlands.
- How much did NewAmsterdam Pharma raise?
- NewAmsterdam Pharma raised $196 Million in a Series A round on January 14, 2021.
- What does NewAmsterdam Pharma do?
- Founded in 2019, NewAmsterdam Pharma is a late-stage clinical biopharmaceutical company focused on the research and development of transformative therapies for cardiometabolic diseases.
- Where is NewAmsterdam Pharma based and how big is it?
- NewAmsterdam Pharma is based in Netherlands.
- Who are the decision-makers at NewAmsterdam Pharma?
- Fundz holds 1 contact at NewAmsterdam Pharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as NewAmsterdam Pharma that raised within 45 days of this round, from Fundz verified event records.
- Artiva Biotherapeutics raised $120M (Series B) on February 26, 2021.
- Vera Therapeutics, Inc. raised $71M on February 25, 2021.
- Silence Therapeutics plc raised $45M on February 18, 2021.
- Phio Pharmaceuticals raised $14M on February 16, 2021.
- Oragenics raised $21M (Series C) on February 12, 2021.
- Design Therapeutics, Inc. raised $125M on February 12, 2021.
Who to call at NewAmsterdam Pharma, and when
A new round usually means NewAmsterdam Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NewAmsterdam Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NewAmsterdam Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NewAmsterdam Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NewAmsterdam Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNewAmsterdam Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.